GM
Gordon Murdo Vice-Président Exécutif
Other M
Insider track record Executive Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Gordon Murdo, Vice-Président Exécutif. Director active across 1 company, notably AMGEN INC. Aggregated, 31 filings have been logged. Split: 0 buy · 3 sells. Total volume traded: €6.8m. Activity tracked since 30 April 2021. The latest transaction was filed on 2 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Gordon Murdo Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations 31 total
● EVP, Global Commercial Ops · Executives · 2 May 2026 · AMGEN INC 830 shares @ US$329.82 0.0001% mcap 1.7% of flow Common Stock SEC:0000318154-26-000061:0
● EVP, Global Commercial Ops · Executives · 2 May 2026 · AMGEN INC 763 shares @ US$329.82 0.0001% mcap 1.6% of flow Common Stock SEC:0000318154-26-000061:1
● EVP, Global Commercial Ops · Executives · 16 Mar 2026 · AMGEN INC 6,691 shares @ US$366.21 14.6% of flow Common Stock SEC:0000318154-26-000026:0
◆ EVP, Global Commercial Ops · Executives · 3 Mar 2026 · AMGEN INC 13,403 shares 0Common Stock SEC:0000318154-26-000015:0
▼ EVP, Global Commercial Ops · Executives · 12 Nov 2025 · AMGEN INC 6,879 shares @ US$336.8326 12.0% of flow Common Stock SEC:0000318154-25-000081:0
◆ EVP, Global Commercial Ops · Executives · 6 May 2025 · AMGEN INC 3,919 shares 0Common Stock SEC:0001127602-25-013780:0
● EVP, Global Commercial Ops · Executives · 2 May 2025 · AMGEN INC 780 shares @ US$283.78 1.4% of flow Common Stock SEC:0001127602-25-013527:0
● EVP, Global Commercial Ops · Executives · 2 May 2025 · AMGEN INC 740 shares @ US$283.78 1.4% of flow Common Stock SEC:0001127602-25-013527:1
● EVP, Global Commercial Ops · Executives · 30 Apr 2025 · AMGEN INC 800 shares @ US$288.56 1.5% of flow Common Stock SEC:0001127602-25-013280:0
● EVP, Global Commercial Ops · Executives · 17 Mar 2025 · AMGEN INC 4,039 shares @ US$313.71 8.6% of flow Common Stock SEC:0001127602-25-010054:0
◆ EVP, Global Commercial Ops · Executives · 3 Mar 2025 · AMGEN INC 8,085 shares 0Common Stock SEC:0001127602-25-008422:0
▼ EVP, Global Commercial Ops · Executives · 11 Feb 2025 · AMGEN INC 8,771 shares @ US$294.7947 18.5% of flow Common Stock SEC:0001127602-25-004776:0
◆ EVP, Global Commercial Ops · Executives · 7 May 2024 · AMGEN INC 3,529 shares 0Common Stock SEC:0001127602-24-014852:0
● EVP, Global Commercial Ops · Executives · 5 May 2024 · AMGEN INC 665 shares @ US$311.29 1.4% of flow Common Stock SEC:0001127602-24-014506:0
● EVP, Global Commercial Ops · Executives · 2 May 2024 · AMGEN INC 758 shares @ US$277.37 1.4% of flow Common Stock SEC:0001127602-24-014191:0
● EVP, Global Commercial Ops · Executives · 30 Apr 2024 · AMGEN INC 753 shares @ US$276.38 1.4% of flow Common Stock SEC:0001127602-24-013811:0
● EVP, Global Commercial Ops · Executives · 18 Mar 2024 · AMGEN INC 6,461 shares @ US$268.87 11.8% of flow Common Stock SEC:0001127602-24-010848:0
◆ EVP, Global Commercial Ops · Executives · 6 Mar 2024 · AMGEN INC 12,924 shares 0Common Stock SEC:0001127602-24-009239:0
▼ EVP, Global Commercial Ops · Executives · 10 Aug 2023 · AMGEN INC 9,558 shares @ US$262.43 16.8% of flow Common Stock SEC:0001127602-23-022410:0
● EVP, Global Commercial Ops · Executives · 5 May 2023 · AMGEN INC 623 shares @ US$231.89 1.0% of flow Common Stock SEC:0001127602-23-015044:0
◆ EVP, Global Commercial Ops · Executives · 2 May 2023 · AMGEN INC 4,237 shares 0Common Stock SEC:0001127602-23-014608:0
● EVP, Global Commercial Ops · Executives · 30 Apr 2023 · AMGEN INC 728 shares @ US$239.74 1.2% of flow Common Stock SEC:0001127602-23-014150:0
● EVP, Global Commercial Ops · Executives · 17 Mar 2023 · AMGEN INC 3,978 shares @ US$234.57 6.5% of flow Common Stock SEC:0001127602-23-010914:0
◆ EVP Global Commercial Ops · Executives · 6 Mar 2023 · AMGEN INC 7,947 shares 0Common Stock SEC:0001127602-23-009504:0
● EVP Global Commercial Ops · Executives · 22 Aug 2022 · AMGEN INC 400 shares 0Common Stock SEC:0001127602-22-021473:0
25 of 31 declarations
Load more (6 remaining) About Gordon Murdo Gordon Murdo is Executive Vice President and EVP, Global Commercial Ops at AMGEN INC (XNAS). The declarant has 31 filings in total, and in the sampled period from 2021-05-04 to 2026-05-05 the recorded transactions were all sales, for a total of EUR 6793684, with Retenue fiscale as the modal transaction nature.